1. ALLA AKTIER
  2. NYHETER
  3. MAGLE CHEMOSWED

Magle Chemoswed

Nyheter Magle Chemoswed Nyheter alla bolag
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

Magle Chemoswed Holding AB (publ) Releases Annual Report for 2022.

MARKN.

Magle Chemoswed Holding's Annual Report for 2022 has been published on the Group’s website as of today.

The annual report is available as a downloadable PDF document at www.maglegroup.com

"In 2022, we continued to deliver solid revenue growth and improved profitability, based on our long-term strategy to create value for shareholders, business partners, and patients all over the globe," said Justin Pierce, Magle Chemoswed's CEO.

Petra Jönsson Sjölin, Magle Chemoswed's CFO, said, "These operating results across our business areas are evidence of our balanced risk-to-growth approach whilst implementing our growth strategy working".

Contacts

Megi Medzmariashvili, Legal Counsel, phone +46 (0)76 164 33 12, megi.medzmariashvili@maglechemoswed.com

About Us

The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes two operational areas. Magle Chemoswed – a contract development and manufacturing organization (CDMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle PharmaCept – an established sales and marketing company for development and direct sales of the Groups medical technology products. Learn more on www.maglechemoswed.com and https://maglegroup.com/ and www.maglepharmacept.com

Vator Securities is the Company's certified adviser on Nasdaq First North Growth Market and can be reached at ca@vatorsec.se or +46 (0)8-580 065 99.

Attachments

MCSH Annual Report 2022

Datum 2023-03-29, kl 15:55
Källa MFN
Bifogade filer
MCSH Annual Report 2022